Predictive Value of Inflammatory and Nutritional Indexes in the Pathology of Bladder Cancer Patients Treated with Radical Cystectomy.

bladder cancer derived neutrophil-to-lymphocyte ratio geriatric nutritional risk index inflammation nutrition pathology systemic inflammatory response index

Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
21 02 2023
Historique:
received: 07 01 2023
revised: 15 02 2023
accepted: 17 02 2023
medline: 30 3 2023
entrez: 28 3 2023
pubmed: 29 3 2023
Statut: epublish

Résumé

In recent years, the focus of numerous studies has been the predictive value of inflammatory and nutritional parameters in oncology patients. The aim of our study was to examine the relationship between the inflammatory and nutritional parameters and the histopathological characteristics of patients with bladder cancer. A retrospective study included 491 patients who underwent radical cystectomy for bladder cancer between 2017 and 2021. We calculated the preoperative values of the neutrophil-to-lymphocyte ratio (NLR), the derived neutrophil-to-lymphocyte ratio (dNLR), the systemic immune-inflammation index (SII), the systemic inflammatory response index (SIRI), the platelet-to-lymphocyte ratio (PLR), the lymphocyte-to-monocyte ratio (LMR), the prognostic nutritional index (PNI), and the geriatric nutritional risk index (GNRI). Statistically significant positive correlations were observed between NLR, dNLR, SII, SIRI, and PLR and the pathological stage of the tumor. We observed statistically significant inverse correlations for LMR, PNI, and GNRI with the tumor stage. SIRI was identified as an independent predictor of the presence of LVI. dNLR was identified as an independent predictor of positive surgical margins. GNRI was identified as an independent predictor of the presence of metastases in the lymph nodes. We noticed the predictive value of SIRI, dNLR, and GNRI in the pathology of bladder cancer patients.

Identifiants

pubmed: 36975410
pii: curroncol30030197
doi: 10.3390/curroncol30030197
pmc: PMC10047817
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2582-2597

Références

Nature. 2014 Mar 6;507(7490):48-9
pubmed: 24572360
Eur Urol Focus. 2020 Jul 15;6(4):653-663
pubmed: 31530497
Int J Gynecol Cancer. 2009 Aug;19(6):1074-9
pubmed: 19820371
Eur Urol. 2016 Feb;69(2):300-10
pubmed: 26346676
Oncotarget. 2017 Mar 7;8(10):17258-17269
pubmed: 27791991
Int J Surg Pathol. 2005 Apr;13(2):143-53
pubmed: 15864376
AJR Am J Roentgenol. 2000 Sep;175(3):759-66
pubmed: 10954463
Cancer Manag Res. 2020 Oct 01;12:9471-9483
pubmed: 33061634
CA Cancer J Clin. 2016 Jul;66(4):271-89
pubmed: 27253694
Curr Urol. 2017 Apr;10(1):26-31
pubmed: 28559774
Cancer. 2017 Mar 1;123(5):794-801
pubmed: 27787873
Am J Clin Nutr. 2005 Oct;82(4):777-83
pubmed: 16210706
BJU Int. 2014 Jun;113(6):887-93
pubmed: 23906037
J Clin Med. 2022 Sep 23;11(19):
pubmed: 36233472
J Urol. 2010 Jun;183(6):2165-70
pubmed: 20399473
Rev Invest Clin. 2018;70(3):121-125
pubmed: 29943772
Korean J Urol. 2015 Nov;56(11):749-55
pubmed: 26568792
Sci Rep. 2020 Jul 1;10(1):10744
pubmed: 32612136
Lung Cancer. 2017 Sep;111:176-181
pubmed: 28838390
J Clin Oncol. 2001 Feb 1;19(3):666-75
pubmed: 11157016
BJU Int. 2010 Feb;105(3):300-8
pubmed: 19912200
Nat Rev Urol. 2016 Aug;13(8):471-9
pubmed: 27431340
Pancreas. 2006 Jan;32(1):22-8
pubmed: 16340740
World J Gastroenterol. 2014 Aug 28;20(32):11160-81
pubmed: 25170202
Sci Rep. 2018 Aug 22;8(1):12561
pubmed: 30135506
World J Urol. 2019 Sep;37(9):1827-1835
pubmed: 30511214
Blood Purif. 2015;39(4):281-7
pubmed: 25925239
Carcinogenesis. 2009 Jul;30(7):1073-81
pubmed: 19468060
J Clin Lab Anal. 2019 May;33(4):e22833
pubmed: 30666724
Front Oncol. 2022 Oct 21;12:900305
pubmed: 36338698
J Clin Med. 2022 Jun 13;11(12):
pubmed: 35743468
Eur Urol. 2013 Feb;63(2):234-41
pubmed: 22877502
Cancer Commun (Lond). 2018 Mar 12;38(1):2
pubmed: 29764510
Am J Clin Nutr. 1988 Feb;47(2 Suppl):357-65
pubmed: 3124597
Geriatrics. 1989 Apr;44(4):31-4, 37
pubmed: 2647586
Urol Int. 2006;77(1):13-7
pubmed: 16825809
Int J Cancer. 2000 Apr 15;86(2):289-94
pubmed: 10738259
J Clin Oncol. 2008 Jan 20;26(3):380-5
pubmed: 18202413
Nature. 2008 Jul 24;454(7203):436-44
pubmed: 18650914
Int Urol Nephrol. 2015 Jun;47(6):951-8
pubmed: 25894962
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
Front Immunol. 2017 Feb 02;8:71
pubmed: 28210259
Ann Surg. 2006 Jan;243(1):64-73
pubmed: 16371738
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
Pharmacol Res. 2017 May;119:278-288
pubmed: 28212890
Arch Pathol Lab Med. 2019 May;143(5):571-577
pubmed: 30044124
Eur Urol. 2018 Dec;74(6):784-795
pubmed: 30268659
Am J Surg. 1980 Jan;139(1):160-7
pubmed: 7350839
Cancer Res. 1995 Aug 1;55(15):3438-43
pubmed: 7542171
World J Gastroenterol. 2017 Sep 14;23(34):6261-6272
pubmed: 28974892
Front Mol Biosci. 2020 Nov 05;7:575483
pubmed: 33251247
Immunol Invest. 2003 Aug;32(3):201-15
pubmed: 12916709
World J Urol. 2017 Feb;35(2):261-270
pubmed: 27255479
Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G705-17
pubmed: 11518683
Cell Physiol Biochem. 2018;46(4):1352-1364
pubmed: 29689562
Radiology. 1990 Apr;175(1):45-51
pubmed: 2315503
BJU Int. 2016 Apr;117(4):604-10
pubmed: 25851271
BMC Cancer. 2019 Jul 19;19(1):716
pubmed: 31324162
Dig Surg. 2019;36(3):226-232
pubmed: 29672297

Auteurs

Nebojsa Prijovic (N)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.

Miodrag Acimovic (M)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Dr Subotica Str. 8, 11000 Belgrade, Serbia.

Veljko Santric (V)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Dr Subotica Str. 8, 11000 Belgrade, Serbia.

Branko Stankovic (B)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.

Predrag Nikic (P)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Dr Subotica Str. 8, 11000 Belgrade, Serbia.

Ivan Vukovic (I)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Dr Subotica Str. 8, 11000 Belgrade, Serbia.

Ivan Soldatovic (I)

Faculty of Medicine, University of Belgrade, Dr Subotica Str. 8, 11000 Belgrade, Serbia.

Djordje Nale (D)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Dr Subotica Str. 8, 11000 Belgrade, Serbia.

Luka Kovacevic (L)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.

Petar Nale (P)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.

Adrian Marinkovic (A)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.

Uros Babic (U)

Clinic of Urology, University Clinical Center of Serbia, Resavska Str. 51, 11000 Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Dr Subotica Str. 8, 11000 Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH